Navigation Links
Algeta and Lumiphore Announce Global Agreement for the Development of Targeted Alpha-Pharmaceutical Therapeutics
Date:10/21/2010

tibodies using existing non-proprietary chelates , Algeta has already demonstrated in vivo the potential of its proprietary technology for enhancing the performance of radio-immunotherapies based on existing clinical antibodies. We believe that the new chelators will provide even better results."

Lumi4® complexes are a new class of metal lanthanide and actinide chelators based on technology patented by Professor Kenneth N. Raymond and coworkers at the University of California, Berkeley and modified by Lumiphore. This unique patent family is focused on a novel cage structure surrounding lanthanide ions which enables them to be tightly held and covalently attached to receptor targeting molecules.

This is the fourth major agreement reached by Lumiphore in the past four years. Previous partnerships include Thermo Fisher Scientific Specialty Diagnostics (www.thermofisher.com) for certain diagnostic tests to be used in both in laboratories and point-of-care-formats including Downs Syndrome; Cis Bio International (www.htrf.com/company/partners/) for the drug discovery research market; and Biophor Diagnostics Inc. (www.biophor.com) for diagnostic tests for drugs of abuse.

About Lumiphore, Inc.Based in Richmond, California, Lumiphore Inc, a privately held company, is a biotechnology leader in the development of proprietary fluorescent-metal lanthanide and chelation technology for use in high-value imaging and therapeutic applications which are commercialized through market-specific alliances with corporate partners. Lumiphore has exclusive licenses to the basic science developed at the University of California, Berkeley in the laboratory of Professor Kenneth N. Raymond, a world expert on lanthanide chemistry. For more information about Lumiphore, log onto www.lumiphore.com<
'/>"/>

SOURCE Lumiphore, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer
2. Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
3. Boston Scientific Announces FDA Clearance and CE Mark Approval for Advanix™ Biliary Stents
4. Celtic Pharma Announces Issuance of U.S. Patent 7,816,323 for Xerecept® in Combination with Avastin® as a Treatment for Breast and Colon Cancers
5. Hanger Orthopedic Group, Inc. Announces Pricing of $200 Million of Senior Notes
6. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter and Nine-Months Ended September 30, 2010 and Declares Quarterly Dividend
7. K-V Pharmaceutical Company Announces Establishment of New Generic Marketing Subsidiary and Senior Executive Appointment
8. Endo Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 1, 2010
9. MacroGenics and Lilly Announce Pivotal Clinical Trial of Teplizumab Did Not Meet Primary Efficacy Endpoint
10. Amgen Announces Webcast of 2010 Third Quarter Financial Results
11. ERT to Announce Third Quarter 2010 Results on November 4, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Mass. , Aug. 27, 2014 North American ... a prestigious R&D 100 Award for the new OSRAM ITOS ... and LED-based white light module for microscopy, endoscopy and surgical ... lamps with significantly higher efficacy and lamp life. ... as one of the most innovative new technologies of the ...
(Date:8/27/2014)... STATESVILLE, N.C. , Aug. 27, 2014 ... today its Board of Directors increased its quarterly cash ... from eleven cents per outstanding share, beginning with the ... record at the close of business on September 8, ... Founded in 1906, Kewaunee Scientific Corporation is ...
(Date:8/27/2014)... , Aug. 27, 2014  Columbia Laboratories, Inc. (Nasdaq: ... provider of pharmaceutical development, clinical trial manufacturing, and advanced ... announced that it will participate at the upcoming Rodman ... to be held in New York ... 11:15am on September 9, 2014 at the New York ...
Breaking Medicine Technology:OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3
(Date:8/27/2014)... August 27, 2014 Skirt Sports , ... its partnership with pioneer runner, Kathrine Switzer, most noted for ... The collaboration creates a line of women’s running clothes that ... message of Kathrine’s 261 Fearless Movement. , “It ... icon,” said Nicole DeBoom. “Kathrine is the original Skirt ...
(Date:8/27/2014)... 2014 New Jersey’s own Morgan Hoffmann ... County Club during The Barclays – and thanks to ... the tournament’s four rounds, stepped his way into raising ... Blue Shield of New Jersey (Horizon BCBNSNJ) Walking Challenge. ... native playing before family and friends at the Paramus ...
(Date:8/27/2014)... Dennis Thompson HealthDay ... Someone who has been mugged in a dark alley will ... with a fear of being attacked. But neuroscientists working ... how memories are linked with positive and negative emotions. And ... emotions attached to a memory. In essence, they made ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Ticket Down ... Chile tickets at Levi’s Stadium in Santa Clara. ... Santa Clara, California just opened in July and will host ... Mexico takes on Chile. These are two of the best ... 2014 World Cup and will look to continue their successes ...
(Date:8/27/2014)... lipids are known to play a key role in ... like atherosclerosis. A new study at UCLA demonstrates that ... lung disease that narrows the small blood vessels in ... showed that a peptide mimicking part of the main ... may help reduce the production of oxidized lipids in ...
Breaking Medicine News(10 mins):Health News:Skirt Sports Launches Clothing Line with Legendary Runner Kathrine Switzer 2Health News:Morgan Hoffmann, PGA TOUR Pro & Wyckoff Native, golfs and walks his way to top 10 finish at The Barclays while raising additional $7,500 for charity 2Health News:Scientists 'Rewrite' Bad Memories in Mice 2Health News:Scientists 'Rewrite' Bad Memories in Mice 3Health News:Mexico vs. Chile Tickets at Levi’s Stadium: Ticket Down Cuts Ticket Prices for Inaugural Soccer Match between Chile and Mexico in Santa Clara 2Health News:Mexico vs. Chile Tickets at Levi’s Stadium: Ticket Down Cuts Ticket Prices for Inaugural Soccer Match between Chile and Mexico in Santa Clara 3Health News:Protein in 'good cholesterol' may be a key to treating pulmonary hypertension 2
... Md., Jan. 7 Hanger Orthopedic Group, Inc. (NYSE: ... its results of operations for the year ended December 31, ... a press release announcing the results for the year ended ... close of the market. The conference call is scheduled to ...
... identified mutations in a gene that predict a high ... (ALL). Although the researchers caution that further research is ... IKZF1 or IKAROS, lead to leukemia relapse, the findings ... tests to assess the risk of treatment failure. ...
... to Provide Support and Convenience CARLSBAD, Calif., Jan. ... of a new on-line service for physicians and ... and products. The new Web site, www.skinmedica.com ... physicians while offering the convenience of on-line information ...
... Seabrook House, an internationally recognized inpatient treatment center, is ... programs in 2009. The following is just a few ... that recovery from addiction is possible and that treatment works. ... family who needs it and to educate the public at ...
... (NYSE: MED ), a leading portion-controlled weight-loss program, ... Baltimore SmartCEO magazine. Medifast is a 2007 and ... the 50 fastest growing companies in the Greater Baltimore area ... 16, 2008 that The Company expects revenues in excess of ...
... Colo., Jan. 7 Zuma,s Rescue Ranch received its ... years of being self funded, Zuma,s Rescue Ranch can ... had a very busy 2008, along with formally becoming ... Health Institute on getting Medicaid to cover Equine Assisted ...
Cached Medicine News:Health News:Hanger Orthopedic Group, Inc. Announces 2008 Year-End Earnings Release Conference Call 2Health News:Gene abnormality found to predict childhood leukemia relapse 2Health News:Gene abnormality found to predict childhood leukemia relapse 3Health News:Gene abnormality found to predict childhood leukemia relapse 4Health News:SkinMedica Launches On-Line Service for Physician Partners 2Health News:Seabrook House Embraces the New Year with New Programs 2Health News:Seabrook House Embraces the New Year with New Programs 3Health News:Medifast Named Baltimore SmartCEO Future 50 Company for Second Time 2
Calcar replacement stems provide options for revision and trochanteric fractures. Revision hip surgery and trauma often require prosthetic designs that replace proximal medial calcar bone loss....
...
...
... for the restoration of shoulder joint ... surgery. Backed by the clinical expertise ... the Bigliani/Flatow Shoulder System is designed ... balance, and stability with a multitude ...
Medicine Products: